206 related articles for article (PubMed ID: 16210564)
1. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Telford DE; Lipson SM; Barrett PH; Sutherland BG; Edwards JY; Aebi JD; Dehmlow H; Morand OH; Huff MW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2608-14. PubMed ID: 16210564
[TBL] [Abstract][Full Text] [Related]
2. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
4. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
[TBL] [Abstract][Full Text] [Related]
6. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin.
Morand OH; Aebi JD; Dehmlow H; Ji YH; Gains N; Lengsfeld H; Himber J
J Lipid Res; 1997 Feb; 38(2):373-90. PubMed ID: 9162756
[TBL] [Abstract][Full Text] [Related]
7. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
Huff MW; Telford DE; Edwards JY; Burnett JR; Barrett PH; Rapp SR; Napawan N; Keller BT
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1884-91. PubMed ID: 12426220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo.
Eisele B; Budzinski R; Müller P; Maier R; Mark M
J Lipid Res; 1997 Mar; 38(3):564-75. PubMed ID: 9101437
[TBL] [Abstract][Full Text] [Related]
12. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
[TBL] [Abstract][Full Text] [Related]
13. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
Himber J; Missano B; Rudling M; Hennes U; Kempen HJ
J Lipid Res; 1995 Jul; 36(7):1567-85. PubMed ID: 7595080
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
Peffley DM; Gayen AK; Morand OH
Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
Telford DE; Edwards JY; Lipson SM; Sutherland B; Barrett PH; Burnett JR; Krul ES; Keller BT; Huff MW
J Lipid Res; 2003 May; 44(5):943-52. PubMed ID: 12562847
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.
Telford DE; Sutherland BG; Edwards JY; Andrews JD; Barrett PH; Huff MW
J Lipid Res; 2007 Mar; 48(3):699-708. PubMed ID: 17130282
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults.
Brämswig S; Kerksiek A; Sudhop T; Luers C; Von Bergmann K; Berthold HK
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H704-16. PubMed ID: 11788421
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil.
Huff MW; Telford DE; Edmonds BW; McDonald CG; Evans AJ
Biochim Biophys Acta; 1993 Dec; 1210(1):113-22. PubMed ID: 8257713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]